Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.


Hematopoietic Stem Cells VIII

Edited by Edited by Lothar Kanz (University of Tübingen, Tübingen, Germany), Willem E. Fibbe (Leiden University Medical Center,Leiden, the Netherlands), Claudia Lengerke (University of Tübingen, Tübingen, Germany), and John E. Dick (University of Toronto, Toronto, Ontario, Canada).
Hematopoietic Stem Cells VIII

Published: August 2012

Volume 1266

Contemporary reviews chronicling the new boundaries in hematopoietic stem research.
Learn More

This volume stems from the eighth international symposium and workshop entitled “Hematopoietic Stem Cells VIII” held and hosted by the University of Tübingen, Germany in the fall of 2011. The meeting was designed to bring leading scientists together to discuss the state-of-the-art in the field of hematopoietic stem cells. Topics reviewed in this volume include differential requirements for Wnt and Notch signaling in hematopoietic versus thymic niches; hematopoietic stem cell expansion; TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia; regulatory factors for hematopoietic stem cells; reprogramming factors; immune reconstitution and strategies for rebuilding of the immune system after haploidentical stem cell transplantation; zebrafish xenografts as a tool for in vivo studies on human cancer; enhancing engraftment of cord blood cells; current insights into neutrophil homeostasis; and molecular live cell bioimaging in stem cell research, among others.